A systematic review on natural medicines for the prevention and treatment of Alzheimer's disease with meta-analyses of intervention effect of ginkgo

American Journal of Chinese Medicine

Volumn 42, Issue 3, 2014, Pages 505-521

  Yang, Mengmeng ^a   Xu, Dan Dan ^a   Zhang, Yan ^a   Liu, Xinyou ^a   Hoeven, Robin ^b   Cho, William Chi Shing ^c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Alzheimer's Disease; Ginkgo; Meta Analysis; Natural Medicines; Systematic Review

Indexed keywords

CROCUS SATIVUS EXTRACT; CURCUMIN; DONEPEZIL; FUZHISAN EXTRACT; GINKGO BILOBA EXTRACT; HUPERZINE A; NATURAL PRODUCT; PLACEBO; SALVIA OFFICINALIS EXTRACT; UNCLASSIFIED DRUG; PLANT EXTRACT;

ALZHEIMER DISEASE; COGNITION; DAILY LIFE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; GINKGO BILOBA; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; BIBLIOGRAPHIC DATABASE; PHYTOTHERAPY; PSYCHOLOGY;

ALZHEIMER DISEASE; COGNITION; DATABASES, BIBLIOGRAPHIC; GINKGO BILOBA; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84901803469     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X14500335     Document Type: Review

References (41)

1. Akhondzadeh, S., M. Noroozian, M. Mohammadi, S. Ohadinia, A.H. Jamshidi and M. Khani. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomized and placebo-controlled trial. J. Clin. Pharm. Ther. 28: 53-59, 2003.
2. Akhondzadeh, S., M. Noroozian, M. Mohammadi, S. Ohadinia, A.H. Jamshidi and M. Khani. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomised, placebo controlled trial. J. Neurol. Neurosurg. Psychiatr. 74: 863-866, 2003.
3. Akhondzadeh, S., M.S. Sabet, M.H. Harirchian, M. Togha, H. Cheraghmakani, S. Razeghi, S. Hejazi, M.H. Yousefi, R. Alimardani, A. Jamshidi, F. Zare and A. Moradi. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: A 16-week, randomized and placebocontrolled trial. J. Clin. Pharm. Ther. 35: 581-588, 2010.
4. Baum, L., C.W. Lam, S.K. Cheung, T. Kwok, V. Lui, J. Tsoh, L. Lam, V. Leung, E. Hui, C. Ng, J. Woo, H.F. Chiu, W.B. Goggins, B.C. Zee, K.F. Cheng, C.Y. Fong, A. Wong, H. Mok, M.S. Chow, P.C. Ho, S.P. Ip, C.S. Ho, X.W. Yu, C.Y. Lai, M.H. Chan, S. Szeto, I.H. Chan and V. Mok. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol. 28: 110-113, 2008.
5. Bi, M., S. Tong, Z. Zhang, Q. Ma, S. Zhang, Z. Luo, Y. Zhang, X. Li and D. Wang. Changes in cerebral glucose metabolism in patients with mild-To-moderate Alzheimer's disease: A pilot study with the Chinese herbal medicine Fuzhisan. Neurosci. Lett. 501: 35-40, 2011.
6. Burns, A., E. Perry, C. Holmes, P. Francis, J. Morris, M.J. Howes, P. Chazot, G. Lees and C. Ballard. A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 31: 158-164, 2011.
7. DeKosky, S.T., J.D. Williamson, A.L. Fitzpatrick, R.A. Kronmal, D.G. Ives, J.A. Saxton, O.L. Lopez, G. Burke, M.C. Carlson, L.P. Fried, L.H. Kuller, J.A. Robbins, R.P. Tracy, N.F. Woolard, L. Dunn, B.E. Snitz, R.L. Nahin and C.D. Furberg. Ginkgo biloba for prevention of dementia: A randomized controlled trial. JAMA 300: 19: 2253-2262, 2008.
8. Dodge, H.H., T. Zitzelberger, B.S. Oken, D. Howieson and J. Kaye. A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology 70: 1809-1817, 2008.
9. Dos Santos-Neto, L.L., M.A. de Vilhena Toledo, P. Medeiros-Souza and G.A. de Souza. The use of herbal medicine in Alzheimer's disease-A systematic review. Evid. Based Complement. Alternat. Med. 3: 441-445, 2006.
10. Eckert, A. Mitochondrial effects of Ginkgo biloba extract. Int. Psychogeriatr. 24(Suppl 1): S18-S20, 2012.
11. Heo, J.H., S.T. Lee, K. Chu, M.J. Oh, H.J. Park, J.Y. Shim and M. Kim. An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease. Eur. J. Neurol. 15: 865-868, 2008.
12. Heo, J.H., S.T. Lee, M.J. Oh, H.J. Park, J.Y. Shim, K. Chu and M. Kim. Improvement of cognitive deficit in Alzheimer's disease patients by long term treatment with Korean red ginseng. J. Ginseng Res. 35: 457-461, 2011.
13. Herrschaft, H., A. Nacu, S. Likhachev, I. Sholomov, R. Hoerr and S. Schlaefke. Ginkgo biloba extract EGb 761(R) in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. J. Psychiatr. Res. 46: 716-723, 2012.
14. Ihl, R., M. Tribanek and N. Bachinskaya. Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761(R) in Alzheimer's disease and vascular dementia: Results from a randomised controlled trial. Pharmacopsychiatry 45: 41-46, 2012.
15. Jadad, A.R., R.A. Moore, D. Carroll, C. Jenkinson, D.J.M. Reynolds, D.J. Gavaghan and H.J. McQuay. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control. Clin. Trials 17: 1-12, 1996. (Pubitemid 26120810)
16. Janssen, I.M., S. Sturtz, G. Skipka, A. Zentner, M. Velasco Garrido and R. Busse. Ginkgo biloba in Alzheimer's disease: A systematic review. Wien. Med. Wochenschr. 160: 539-546, 2010.
17. Kanowski, S., W.M. Herrmann, K. Stephan, W. Wierich and R. Horr. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Phytomedicine 4: 3-13, 1997. (Pubitemid 127568204)
18. Kanowski, S. and R. Hoerr. Ginkgo biloba extract EGb 761 in dementia: Intent-To-Treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry 36: 297-303, 2003. (Pubitemid 38085148)
19. Le Bars, P.L., M.M. Katz, N. Berman, T.M. Itil, A.M. Freedman and A.F. Schatzberg. A placebocontrolled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 278: 1327-1332, 1997. (Pubitemid 27449692)
20. Le Bars, P.L., M. Kieser and K.Z. Itil. A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb 761 in dementia. Dement. Geriatr. Cogn. Disord. 11: 230-237, 2000.
21. Le Bars, P.L., F.M. Velasco, J.M. Ferguson, E.C. Dessain, M. Kieser and R. Hoerr. Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract EGb 761 in Alzheimer's disease. Neuropsychobiology 45: 19-26, 2002. (Pubitemid 34117724)
22. Lee, S.T., K. Chu, J.Y. Sim, J.H. Heo and M. Kim. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer. Dis. Assoc. Disord. 22: 222-226, 2008.
23. Man S.C., S.S. Durairajan, W.F. Kum, J.H. Lu, J.D. Huang, C.F. Cheng, V. Chung, M. Xu and M. Li. Systematic review on the efficacy and safety of herbal medicines for Alzheimer's disease. J. Alzheimer Dis. 14: 209-223, 2008. (Pubitemid 352040038)
24. Mancuso, C., R. Siciliano, E. Barone and P. Preziosi. Natural substances and Alzheimer's disease: From preclinical studies to evidence based medicine. Biochim. Biophys. Acta 1822: 616-624, 2012.
25. Maurer, K., R. Ihl, T. Dierks and L. Frölich. Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J. Psychiatr. Res. 31: 645-655, 1997.
26. Mazza, M., A. Capuano, P. Bria and S. Mazza. Ginkgo biloba and donepezil: A comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. Eur. J. Neurol. 13: 981-985, 2006.
27. Muller, W.E., J. Heiser and K. Leuner. Effects of the standardized Ginkgo biloba extract EGb 761(R) on neuroplasticity. Int. Psychogeriatr. 24(Suppl 1): S21-S24, 2012.
28. Napryeyenko, O., G. Sonnik and I. Tartakovsky. Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: Analyses of a randomised controlled trial. J. Neurol. Sci. 283: 224-229, 2009.
29. Perry, E.K., A.T. Pickering, W.W. Wang, P.J. Houghton and N.S.L. Perry. Medicinal plants and Alzheimer's disease: From ethnobotany to phytotherapy. J. Pharm. Pharmacol. 51: 527-534, 1999.
30. Rafii, M.S., S. Walsh, J.T. Little, K. Behan, B. Reynolds, C. Ward, S. Jin, R. Thomas and P.S. Aisen. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology 76: 1389-1394, 2011.
31. Rendeiro, C., J.D. Guerreiro, C.M. Williams and J.P. Spencer. Flavonoids as modulators of memory and learning: Molecular interactions resulting in behavioural effects. Proc. Nutr. Soc. 71: 246-262, 2012.
32. Schneider, L.S., S.T. DeKosky, M.R. Farlow, P.N. Tariot, R. Hoerr and M. Kieser. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Curr. Alzheimer. Res. 2: 541-551, 2005.
33. Scripnikov, A., A. Khomenko and O. Napryeyenko. Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: Findings from a randomised controlled trial. Wien. Med. Wochenschr. 157: 295-300, 2007.
34. Selkoe, D.J. Alzheimer's disease: Genes, proteins, and therapy. Physiol. Rev. 81: 741-766, 2001.
35. Snitz, B.E., E.S. O'Meara, M.C. Carlson, A.M. Arnold, D.G. Ives, S.R. Rapp, J. Saxton, O.L. Lopez, L.O. Dunn, K.M. Sink and S.T. DeKosky. Ginkgo biloba for preventing cognitive decline in older adults: A randomized trial. JAMA 302: 2663-2670, 2009.
36. Sterne, J.A.C., A.J. Sutton, J.P.A. Ioannidis, N. Terrin, D.R. Jones, J. Lau, J. Carpenter, G. Rücker, R.M. Harbord, C.H. Schmid, J. Tetzlaff, J.J. Deeks, J. Peters, P. Macaskill, G. Schwarzer, S. Duval, D.G. Altman, D. Moher and J.P.T. Higgins. Recommendations for examining and interpreting funnel plot asymmetry in meta-Analyses of randomised controlled trials. BMJ 343: D4002, 2011.
37. Vellas, B., N. Coley, P.J. Ousset, G. Berrut, J.F. Dartigues, B. Dubois, H. Grandjean, F. Pasquier, F. Piette, P. Robert, J. Touchon, P. Garnier, H. Mathiex-Fortunet and S. Andrieu. Long-Term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): A randomised placebo-controlled trial. Lancet Neurol. 11: 851-859, 2012.
38. Walker E., A.V. Hernandez and M.W. Kattan. Meta-Analysis: Its strengths and limitations. Cleve. Clin. J. Med. 75: 431-439, 2008.
39. Weinmann, S., S. Roll, C. Schwarzbach, C. Vauth and S.N. Willich. Effects of Ginkgo biloba in dementia: Systematic review and meta-Analysis. BMC Geriatr. 10: 14, 2010.
40. Xu, S.S., Z.Y. Cai, Z.W. Qu, R.M. Yang, Y.L. Cai, G.Q. Wang, X.Q. Su, X.S. Zhong, R.Y. Cheng, W.A. Xu, J.X. Li and B. Feng. Huperzine-A in capsules and tablets for treating patients with Alzheimer disease. Zhongguo Yao Li Xue Bao 20: 6: 486-490, 1999. (Pubitemid 29302406)
41. Yancheva, S., R. Ihl, G. Nikolova, P. Panayotov, S. Schlaefke and R. Hoerr. Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind, exploratory trial. Aging Ment. Health 13: 183-190, 2009.